<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-pharmaceuticals-13-00096">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kakuda</surname>
    <given-names>T.N.</given-names>
   </name>
   <name>
    <surname>Van De Casteele</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Petrovic</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Neujens</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Salih</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Opsomer</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hoetelmans</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Bioequivalence of a darunavir/cobicistat fixed-dose combination tablet versus single agents and food effect in healthy volunteers</article-title>
  <source>Antivir. Ther.</source>
  <year>2014</year>
  <volume>19</volume>
  <fpage>597</fpage>
  <lpage>606</lpage>
  <pub-id pub-id-type="doi">10.3851/IMP2814</pub-id>
  <pub-id pub-id-type="pmid">24964392</pub-id>
 </element-citation>
</ref>
